Yet another reason for judicious use of antibiotics

Article

As if increasing rates of antimicrobial resistance were not enough to discourage excessive use of antimicrobial agents, now it seems that antibiotic use is associated with an increased risk of breast cancer.

Researchers conducted a case–control study of 2,266 women older than 19 years with primary invasive breast cancer. They found that the risk of incident and fatal breast cancer increased as did the total number of days of antibiotic use, from an odds ratio for incidence of 1.45 for 1 to 50 days of use to an odds ratio of 2.07 for greater than 1,000 days of use (P<0.001). Increased risk was associated with all antibiotic classes, but not with tetracycline or macrolides used strictly for acne or rosacea.

Researchers are uncertain whether the antibiotics themselves increase the risk of breast carcinoma or whether a weakened immune system predisposes certain women to both an increased number of infections requiring antibiotic treatment and to breast cancer.

Velicer CM, Heckbert SR, Lampe JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291:827-835.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.